An integrated, specialty healthcare company.

Concordia is a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs. Concordia trades on the NASDAQ Global Select Market® under the symbol CXRX, and on the Toronto Stock Exchange under the symbol CXR.

  • View Stock Information

  • View Stock Information

  • Latest News

  • Downloads

    2017 Second Quarter Report

    2017 First Quarter Report

    2016 Annual Report

    2016 Third Quarter Report

    2016 Second Quarter Report


    View Financials

  • Events

  • Investor Relations

    For investor-related queries, please contact:

    1 905 842 5150